Ventricular tachycardia triggered by the first dose of an adenoviral vector-based COVID-19 vaccine in an adult patient with congenital heart disease.

Clin Case Rep · 2022 · PMC9468566 · PMID 36172331

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

quite significantno p-value reported

1 However, some quite significant adverse events have been detected following the administration of both recombinant adenoviral vector‐based and m‐RNA‐based vaccines.

also in 5,695 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.